CIK 0001712762 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465211056
- Phone
- 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K/A Event Exhibits
- S-8 POS Other Post-effective Amendment
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- RW Other RW
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Executive or director change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DRS Other Draft Registration Statement
Page 15 of 21 · 401 filings